Autopsy report · NCT04695340
Effect of Psyllium (Plantago Ovata) on Digestive Disorders in Familial Amyloidosis
Cause of deathSlow enrollment
“No inclusion during the authorised period, no extension is possible again”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Sponsor type
- University, hospital or other
- Conditions
- Familial Amyloidosis
- Interventions
- Psyllium
- Participants
- 0
- Sites
- 1
- Countries
- France
Trials that died the same way
- Potassium Chloride in Out-of-hospital Cardiac Arrest Due to Refractory Ventricular Fibrillation
“As the inclusion period in the study has ended and regulatory authorizations have expired on 26/12/2023, with no inclusions conducted.” - Study of the Visual Perception During Emotional States on Subjects With an Intrusive Disorder of the Development
“end of inclusion period”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.